EUVIMED · CrossrefZeitschrift
NeuroImmune Pharmacology and Therapeutics
ISSN 2750-6665 · Walter de Gruyter GmbH
Neueste Artikel
Lower cerebrovascular reactivity in HIV-associated cognitive impairment: compared with normal aging and vascular cognitive impairment
Neuroimmune, neurochemical and behavioral studies in humanized heterozygous-IL-34 and wild-type NOG mice
Mind over microglia: using mindfulness-based interventions to target stress-induced neuroinflammatory mediators to improve behavioral symptoms
Cell-based therapy for HIV brain reservoirs: glial progenitors delivering broadly neutralizing antibodies
Liver-derived FGF21 contributes to protection against Alzheimer’s disease pathogenesis
Nicotine-induced enhancement of recognition memory through conserved neuronal development networks in rat and human experimental models
Cellular dry mass and volume dynamics in methamphetamine-induced apoptosis determined by label-free quantitative phase imaging
Emerging drug delivery system to the brain: using extracellular vesicles and liposomes hybrid platform
Chronic administration of methamphetamine downregulates vesicular monoamine transporter2-mediated dopamine dynamics in the nucleus accumbens of inducible HIV-1 Tat transgenic mice
Hantavirus: epidemiology, pathogenesis, clinical features, transmission, and therapeutic strategies
Inflammasome-imprinted stem cells: how NLRP3 signaling reprograms stem cell fate, function, and therapeutic efficacy
Temporal shifts in adaptive immunity drive HIV-associated cryptococcal IRIS: mechanisms, models, and therapeutic opportunities
The role of HIV-1 viral proteins in HIV-associated brain injury: emerging mechanisms and recent advances
Frontmatter
Short-term oxycodone exposure produces delayed and persistent gut microbiome disruption in mice
Selective inhibition of TLR2 stimulates the maturation of oligodendroglial progenitor cells to oligodendrocytes
Non-invasive Raman biomarkers for monitoring fentanyl-induced neurotoxicity in human microglia
Loss of AMPK potentiates inflammation by activating the infammasome in a preclinical mouse model of TBI
CEST MRI assessment of HIV-1-associated neurometabolic impairments in a humanized mouse model
Neonatal morphine and HIV synergy induce persistent neuroimmune and anxiety-related transcriptional states
Analyses of astrocyte-neuron lactate shuttle transporter levels in brain tissues from people with HIV-associated neurocognitive impairment and Alzheimer’s disease
HIV-1 Tat expression drives progressive synaptic decline: evidence from longitudinal [ 11 C]-UCB-J PET imaging
Spreading of the new rat hepatitis E virus (rHEV) into humans
HIV-associated sensory neuropathy: current progress and future challenges
Socioeconomic status and economic hardship attenuated the associations between early tobacco or nicotine use and brain outcomes in preadolescent children
Neurovirulent and non-neurovirulent strains of HIV-1 and their Tat proteins induce differential cytokine-chemokine profiles
Biodegradable cannabidiol: a potential nanotherapeutic for neuropathic pain
Elevated cerebral oxygen extraction in patients with post-COVID conditions
Prenatal tobacco exposure on brain morphometry partially mediated poor cognitive performance in preadolescent children
Blood-brain barrier breakdown in COVID-19 ICU survivors: an MRI pilot study
EUVIMED